CPRX R&D Expenses
Catalyst Pharmaceuticals Inc · R&D Expenses
CPRX R&D Expenses
Latest reported$2.66Mperiod ending
CPRX Quarterly R&D Expenses ($0.00 → $2.66M)
Quarterly R&D Expenses
High-resolution chart · PNG
CPRX r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 2,661,000 | |
| 1,807,000 | |
| 2,657,000 | |
| 4,358,000 | |
| 3,887,000 | |
| 3,798,000 | |
| 3,284,000 | |
| 2,985,000 | |
| 2,581,000 | |
| 1,972,000 | |
| 83,662,000 | |
| 3,954,000 | |
| 3,562,000 | |
| 4,093,000 | |
| 8,310,000 | |
| 3,983,000 | |
| 3,403,000 | |
| 4,992,000 | |
| 4,487,000 | |
| 4,450,000 | |
| 3,007,000 | |
| 4,175,028 | |
| 3,749,000 | |
| 4,349,643 | |
| 4,223,000 | |
| 6,308,390 | |
| 4,597,039 | |
| 4,629,364 | |
| 3,307,959 | |
| 8,416,969 | |
| 4,538,369 | |
| 3,704,824 | |
| 3,259,042 | |
| 3,404,634 | |
| 2,704,923 | |
| 2,451,751 | |
| 2,813,929 | |
| 2,820,654 | |
| 2,494,000 | |
| 2,508,897 | |
| 3,546,391 | |
| 3,831,611 | |
| 3,042,671 | |
| 2,577,508 | |
| 2,349,552 | |
| 2,384,241 | |
| 2,885,892 | |
| 2,098,958 | |
| 2,748,683 | |
| 2,068,083 | |
| 2,804,352 | |
| 2,132,038 | |
| 1,092,301 | |
| 744,692 | |
| 654,837 | |
| 532,741 | |
| 727,327 | |
| 960,240 | |
| 614,137 | |
| 905,635 | |
| 903,953 | |
| 569,168 | |
| 500,091 | |
| 797,935 | |
| 439,587 | |
| 547,557 | |
| 850,998 | |
| 1,376,253 | |
| 2,322,632 | |
| 3,272,359 | |
| 2,451,579 | |
| 1,902,144 | |
| 1,084,359 | |
| 722,011 | |
| 503,348 | |
| 1,002,780 | |
| 762,520 | |
| 320,913 | |
| 235,467 | |
| 216,382 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |